Bulgaria could become Azerbaijan's main pharma supplier, say reports

2 August 2017

Bulgaria could be set to become a major supplier of pharma products to Azerbaijan, according to news sources in both countries.

Bulgarian businessmen and associations have shown great interest in opportunities at an industrial park near Baku that will specialize in the production of pharma products, Nargiz Gurbanova, Azerbaijani ambassador to Bulgaria, has said.

She has spoken of "great prospects for cooperation between the two countries within the pharmaceutical sector" in an interview with Trend News Agency, a news provider from the Caucasus, Caspian and Central Asian regions.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK